L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 14,046 shares at $17.68 ($248K) on 2019-02-19, disclosed to the SEC on 2019-02-20.
Seasonal sale ($248k) by CEO and President — this insider has traded RVNC in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.69 | 3,154 | $56K | 22.5% |
| 2 | $17.68 | 5,446 | $96K | 38.8% |
| 3 | $17.68 | 5,446 | $96K | 38.8% |
| Total | $17.68 avg | 14,046 | $248K | 100% |
| Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |
| RVNC | SELL | 2017-10-20 | $401K | — | Filing → |